News

“Our first hint of external validation:” $5.0-million seed round began with win at the Building a Biotech Venture Pitch Competition

Financing will support the company’s advancement of its 'dual binding' disease therapy

2026-10-20T15:54:01-04:00November 7th, 2024|Categories: Building a Biotech Venture, News|Tags: , , |
Go to Top